ACAD ACAD

Acadia Pharmaceuticals Stock Price

16.96
0.36 (2.17%)
16.96
Volume 1,706,435
Bid Price 16.26
Ask Price 17.00
News -
Day High 16.99

Low
12.24

52 Week Range

High
28.055

Day Low 16.315
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.36 2.17% 16.96 16:31:50
Open Price Low Price High Price Close Price Prev Close
16.60 16.315 16.99 16.96 16.60
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
18,206 1,706,435 $ 16.70 $ 28,490,383 - 12.24 - 28.055
Last Trade Time Type Quantity Stock Price Currency
18:02:46 20 $ 16.26 USD

Period:

Draw Mode:

Acadia Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.74B 161.84M 119.65M $ 484.15M $ -193.32M -1.05 -12.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 167.75k 0.50%

more financials information »

Acadia Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACAD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week16.4016.9915.2116.211,745,8730.563.41%
1 Month15.2316.9913.8015.481,724,8611.7311.36%
3 Months16.6520.3512.2415.812,761,9620.311.86%
6 Months27.189928.05512.2418.422,135,163-10.23-37.62%
1 Year17.5028.05512.2419.301,799,907-0.54-3.09%
3 Years29.3258.7212.2431.151,671,620-12.36-42.16%
5 Years32.1858.7212.2427.171,819,990-15.22-47.3%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.


Your Recent History
NASDAQ
ACAD
Acadia Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now